To add to this using an analogy…
It’s like claiming that infinite compute could enable us to perfectly simulate life on an alien planet we’ve only ever observed through a telescope.
Am I missing something?
Where do the inputs to train this simulation come from? Compute is not the bottleneck in biology.
It’s estimated we have only sequenced genomes for 1% of eukaryotic species, and DNA is just the beginning.
Infinite compute can’t help you simulate a system that’s never even been observed or measured.
@TheWarriorsTalk They gave podz a contract that was 3x too much for his talent. Hes an 9th man on a top 4 team. Then they gave a sick porzingis $20M per year. Now letting a rookie act publicly like an asshole. Its jist terrible mgmt
@PatrickHeizer 10-12 yrs from ind to drug approval, and this guy is talking about cures in 3 yrs for early preclinical projects. I hope these come to fruition but 2040 will be the timeframe when we will see
@JohnStreicher1 Agree. That was total word salad and very few of these people have any clue what they are doing. There is no business model to support current bio AI valuations. Do they know how small the pharma deals are for preclinical molecules?